Mala Gaonkar - SurgoCap Partners की Founder (Hindi version)
In Good Company with Nicolai TangenAI Summary
→ WHAT IT COVERS Nicolai Tangen interviews Mala Gaonkar, founder of SurgoCap Partners, about investing in technology disruption across traditional industries. Gaonkar explains her systematic approach to identifying opportunities where emerging technologies transform non-tech businesses, her team-based decision-making process, and lessons from analyzing enterprise software adoption patterns and incremental returns on invested capital. → KEY INSIGHTS - **Tech-enabled traditional businesses:** Focus on companies in aerospace, materials science, healthcare, and industrial sectors that adopt transformative technologies rather than pure tech plays. Examples include medical imaging enhanced by AI for clarity and speed, Intuitive Surgical combining haptic feedback with mapping software for robotic surgery, and auto manufacturers employing lithium-ion battery innovations. These intersections create durable competitive advantages in established markets. - **Product adoption tracking methodology:** Build investment theses using automated data collection rather than manual surveys. Track Adobe's cloud transition through machine learning web scraping, open APIs for supplier stack mapping, and third party data sources. Combine automated survey bots with human surveyors for deeper analysis. This systematic approach scales product adoption monitoring across multiple portfolio companies and identifies early adoption signals before they appear in financial statements. - **System two thinking framework:** Structure investment decisions through methodical, logical analysis rather than intuitive gut reactions. Use master thesis interviews, checklist-driven approaches, and team-based evaluation to counter cognitive biases like confirmation bias, availability bias, and sunk cost fallacy. Assign team members as coaches or mentors to challenge assumptions. This collaborative process prevents FOMO-driven decisions and ensures thorough vetting of investment theses before capital deployment. - **Incremental return on invested capital:** Evaluate companies based on their ability to generate incremental returns per unit of capital deployed, not just top-line growth. Analyze multiple levers including pricing power, innovation pipeline, market expansion, geographic reach, and product portfolio depth. Balance execution risk against potential returns. This ROIC-focused framework identifies businesses with sustainable competitive advantages and efficient capital allocation rather than chasing revenue growth narratives. - **Portfolio concentration strategy:** Maintain focus across four verticals: enterprise software, financial services, healthcare services, and industrial technologies. Within these sectors, identify where emerging technology disruption creates opportunities for market leaders to build durable moats. Avoid broad diversification in favor of deep expertise in specific domains. This concentrated approach enables pattern recognition across similar business models and better evaluation of management execution capabilities within familiar contexts. → NOTABLE MOMENT Gaonkar shares a formative experience as a junior analyst at the World Bank visiting a local bank branch in Mongolia. The visit crystallized her understanding of how market capitalism and private capital markets operate differently from public markets, shaping her view that private markets often lead in identifying disruptive trends before they become visible in public equity valuations. 💼 SPONSORS None detected 🏷️ Technology Disruption, Investment Strategy, Return On Invested Capital, Enterprise Software, Healthcare Innovation